"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."
Sir John Bell
- Home
- Fundraising
-
About Us
- Founders
- News
- The Trials Acceleration Programme (TAP)
- Our TAP Centres and Nurses
- Where Your Money Goes
- What Our Nurses Do
- Professor Charlie Craddock CBE
- Corporate Partnerships
- Our Trustees and Patrons
- Deutsche Bank Partnership
- The Cure Leukaemia Team
- Publications
- Privacy Policy
- Join The #CLFamily
- Sustainability Policy
- About Leukaemia
- Patient Stories
- The Tour 21
- London 2 Paris 2021
Menu
Fundraising
About Us
About Leukaemia
Patient Stories
The Tour 21
London 2 Paris 2021
- Founders
- News
- The Trials Acceleration Programme (TAP)
- Our TAP Centres and Nurses
- Where Your Money Goes
- What Our Nurses Do
- Professor Charlie Craddock CBE
- Corporate Partnerships
- Our Trustees and Patrons
- Deutsche Bank Partnership
- The Impact Of One Day
- A Message From Cure Leukaemia co-founder Professor Charlie Craddock CBE
- Deutsche Bank's £2m Positive Impact
- Patient Stories
- Working Together - Events To Excite And Engage
- Let's Get Social
- Well-Known Figures Show Their Support For Cure Leukaemia
- The Cure Leukaemia Team
- Publications
- Privacy Policy
- Join The #CLFamily
- Sustainability Policy
Articles tagged with: Purnells
Three New Trustees Appointed
15th May 2014
Deloitte | Pinsent Masons | Purnells
Birmingham-based blood cancer charity Cure Leukaemia has announced a record-breaking 42% increase in their annual fundraising for the year ended October 31st 2013. The charity raised £863,474 last year, a figure that is worth over £8 million in potentially life saving...
PREV
1
NEXT